C15H17BrN4O5S
Neat
445.29
1433875-14-9; ACT 373898; ACT-373898; Macitentan metabolite M5; 18SEV1UJF3; ACT373898; UNII-18SEV1UJF3; 2-[5-(4-bromophenyl)-6-(propylsulfamoylamino)pyrimidin-4-yl]oxyacetic acid; Acetic acid and 2-((5-(4-bromophenyl)-6-(((propylamino)sulfonyl)amino)-4-pyrimidinyl)oxy)-; Act 373898 disodium; C15H17BrN4O5S; orb1694457; SCHEMBL22516164; IHC87514; AKOS040754738; DA-60787; HY-135500; CS-0113290; 2-((5-(4-bromophenyl)-6-((N-propylsulfamoyl)amino)pyrimidin-4-yl)oxy)acetic acid; 2-((5-(4-BROMOPHENYL)-6-(((PROPYLAMINO)SULFONYL)AMINO)-4-PYRIMIDINYL)OXY)ACETIC ACID
2-[5-(4-bromophenyl)-6-(propylsulfamoylamino)pyrimidin-4-yl]oxyacetic acid
InChI=1S/C15H17BrN4O5S/c1-2-7-19-26(23,24)20-14-13(10-3-5-11(16)6-4-10)15(18-9-17-14)25-8-12(21)22/h3-6,9,19H,2,7-8H2,1H3,(H,21,22)(H,17,18,20)